Hepatitis C drug prescriptions and Medicaid policies--four states, Indian health care system, USA 2018

Medicaid, the state-level public insurance in the United States, has widely differing criteria treatment for hepatitis C virus (HCV) such as stage of liver fibrosis, documented sobriety, and specialist consultation. In a rural health network, facilities located in two less restrictive states prescri...

Descripción completa

Detalles Bibliográficos
Autores principales: Reilley, Brigg, Miller, Matt, Hudson, Matt, Haverkate, Rick, Leston, Jessica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894296/
https://www.ncbi.nlm.nih.gov/pubmed/31801547
http://dx.doi.org/10.1186/s12939-019-1101-4
Descripción
Sumario:Medicaid, the state-level public insurance in the United States, has widely differing criteria treatment for hepatitis C virus (HCV) such as stage of liver fibrosis, documented sobriety, and specialist consultation. In a rural health network, facilities located in two less restrictive states prescribed HCV drugs at a significantly higher rate than two more restrictive states (rate ratio 4.7, CI 2.6–8.5). Prescription rates per population were highly associated with HCV treatment policies.

Ejemplares similares